Identifying factors that affect patients' willingness to pay for inhaled insulin

National Diabetes Fact Sheet Behavioral Risk Factor Surveillance System, Prevalence Data American Diabetes Association National Diabetes Information Clearinghouse Center for Disease Control Hunt, 1997, NIDDM patients' fears and hopes about insulin therapy: the basis of patient reluctance, Diabetes Care, 20, 292, 10.2337/diacare.20.3.292 Cappelleri, 2002, Treatment satisfaction in type 2 diabetes: a comparison between inhaled insulin regimen and a subcutaneous insulin regimen, Clin Ther, 4, 552, 10.1016/S0149-2918(02)85131-1 Patton, 1999, Inhaled insulin, Adv Drug Deliv Rev, 35, 235, 10.1016/S0169-409X(98)00074-X U.S. Food and Drug Administration Rave, 2005, Time-action profile of inhaled insulin in comparison with subcutaneously injected insulin Lispro and regular human insulin, Diabetes Care, 28, 1077, 10.2337/diacare.28.5.1077 Barnett, 2004, Exubera inhaled insulin: a review, Int J Clin Pract, 58, 394, 10.1111/j.1368-5031.2004.00178.x Patton, 2004, Clinical pharmacokinetics and pharmacodynamics of inhaled insulin, Clin Pharmacokinet, 43, 781, 10.2165/00003088-200443120-00002 Wall, 2007, Lilly still breathing in inhaler pursuit: Pfizer's lackluster Exubera insulin launch could open door, IBJ Corp Dranitsaris, 2004, Measuring treatment preferences and willingness to pay for docetaxel in advanced ovarian cancer, Pharmacoeconomics, 22, 375, 10.2165/00019053-200422060-00004 Lenert, 2003, Use of willingness to pay to study values for pharmacotherapies for migraine headache, Med Care, 41, 299, 10.1097/01.MLR.0000044909.63278.0D O'Brien, 1995, Assessing the economic value of a new antidepressant. A willingness to pay approach, Pharmacoeconomics, 8, 34, 10.2165/00019053-199508010-00006 Sadri, 2005, Willingness to pay for inhaled insulin: a contingent valuation approach, Pharmacoeconomics, 23, 1215, 10.2165/00019053-200523120-00006 Gerber, 2001, Treatment satisfaction with inhaled insulin in patients with type 1 diabetes mellitus: a randomized controlled trial, Diabetes Care, 24, 1556, 10.2337/diacare.24.9.1556 Rosenstock, 2004, Patient satisfaction and glycemic control after 1 year with inhaled insulin (Exubera) in patients with type 1 or type 2 diabetes, Diabetes Care, 27, 1318, 10.2337/diacare.27.6.1318 Gorsuch, 1997, Exploratory factor analysis: its role in item analysis, J Pers Assess, 68, 532, 10.1207/s15327752jpa6803_5 Guadagnoli, 1988, Relation of sample size to the stability of component patterns, Psychol Bull, 103, 265, 10.1037/0033-2909.103.2.265 Dranitsaris, 2000, The economic value of a new insulin preparation, Humalog mix 25, Pharmacoeconomics, 18, 257, 10.2165/00019053-200018030-00007 Barron, 2004, Feasibility and construct validity of the parent willingness-to-pay technique for children with juvenile idiopathic arthritis, Arthritis Rheum, 51, 899, 10.1002/art.20829 Stevens, 2002 Algina, 2000, Determining sample size for accurate estimation of the squared multiple correlation coefficient, Multivariate Behav Res, 35, 119, 10.1207/S15327906MBR3501_5 Cappelleri, 2000, Development and factor analysis of a questionnaire to measure patient satisfaction with injected and inhaled insulin for Type 1 diabetes, Diabetes Care, 23, 1799, 10.2337/diacare.23.12.1799 Frew, 2001, Willingness-to-pay for colorectal cancer screening, Eur J Cancer, 37, 1746, 10.1016/S0959-8049(01)00200-3 Cross, 2000, Determinants of willingness to pay for hip and knee joint replacement surgery for osteoarthritis, Rheumatology, 39, 1242, 10.1093/rheumatology/39.11.1242 Smith, 2004, Which factors influence willingness-to-pay for orthognathic treatment?, Eur J Orthod, 26, 499, 10.1093/ejo/26.5.499 Catell, 1966, The scree test for number of factors, Multivariate Behav Res, 1, 245, 10.1207/s15327906mbr0102_10 Zethraeus, 1998, Willingness to pay for hormone replacement therapy, Health Econ, 7, 31, 10.1002/(SICI)1099-1050(199802)7:1<31::AID-HEC316>3.0.CO;2-7 Kartman, 1996, Willingness-to-pay for reductions in angina pectoris attacks, Med Decis Making, 16, 248, 10.1177/0272989X9601600309 Nicolucci, 2008, Clinical and socio-economic correlates of quality of life and treatment satisfaction in patients with type 2 diabetes, Nutr Metab Cardiovasc Dis Jonsson, 2000, Gender equity in health care: the case of Swedish diabetes care, Health Care Women Int, 5, 413 Lieu, 2008, Community and patient values for preventing herpes zoster, Pharmacoeconomics, 26, 235, 10.2165/00019053-200826030-00006 Pinto-Prades, 2008, Willingness to pay for a reduction in mortality risk after a myocardial infarction: an application of the contingent valuation method to the case of eplerenone, Eur J Health Econ, 9, 69, 10.1007/s10198-007-0041-x Mahadevia, 2006, Willingness to pay for sensory attributes of intranasal corticosteroids among patients with allergic rhinitis, J Manag Care Pharm, 12, 143, 10.18553/jmcp.2006.12.2.143 Wall St J. Available at: http://online.wsj.com/article/SB119269071993163273.html. Accessed 23.05.08. Riddle, 2002, The underuse of insulin therapy in North America, Diabetes Metab Res Rev, 18, S42, 10.1002/dmrr.277